JPRN-UMIN000001435已完成2 期
Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantation - MP + zoledronic acid therapy for untreated multiple myeloma
Myeloma Bone Disease Study Group0 个研究点目标入组 130 人开始时间: 2008年10月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with prior treatment with intravenous bisphosphonate 2)Those with previous or concomitant malignancy 3)Those with uncontrolled complications or infectious diseases 4)Those with severe cardiac dysfunction( NYHA classification: 3-4) 5)Those who are pregnant or breast-feeding or potential 6)Those who have current active dental problems including infection of the teeth or jawbone. Recent or planned dental or jaw surgery(e.g. extraction, implants) 7)Those known to have active Hepatitis B or C Viral Infection ( HBs(+) or HCV(+) ) 8)Patients participating other clinical studies 9)Those who are inadequate to be enrolled in the protocol study by the investigator
研究者
相似试验
已完成
不适用
A combination of methylprednisolone and prednisolone and a combination of Methylprednisolone, prednisolone and mizoribine for systemic lupus erythematosus in children: A randomized controlled trial of efficacy and safety izolibin for (JSRDC04)systematic lupus erythematosusJPRN-C000000378Japanese Study Group of Renal Disease in Children(JSRDC)60
进行中（未招募）
不适用
Mental disability often occurs after cardiac surgery, which may be due to inflammation of the brain. Prophylactic cortisone treatment may suppress the brain inflammation and reduce the degree of mental disability after cardiac surgery.EUCTR2012-004232-37-SESahlgrenska Universtitetssjukhuset/SUS
已完成
不适用
Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)Steroid-sensitive nephrotic syndromeJPRN-C000000379Japanese Study Group of Renal Disease in Children(JSRDC)50
进行中（未招募）
3 期
PSL/CYA therapy for early onset of VKH diseaseVogt-Koyanagi-Harada diseaseJPRN-jRCTs011180031amba Kenichi120
招募中
2 期
To evaluate the adjuvant potential of methotrexate in mucosal/ limited mucocutaneous pemphigus vulgarisCTRI/2018/07/015002PGIMER